N4 Pharma ( (GB:N4P)) has shared an update. N4 Pharma has announced significant progress in its collaboration with the University of Strathclyde, focusing on the development of its Nuvec® gene ...

Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences those businesses and shapes what we all pay for care. He is also ...

United States President Donald Trump announced new agreements aimed at lowering prescription drug prices. On Friday, alongside leaders from Bristol Myers Squibb, Gilead Sciences, and Merck, among ...

Vik Thapar, president – Corporate Development, Strategy and Finance at Emcure Pharmaceuticals, said the company considered deploying the molecule on its own but found the exclusive distribution ...

Rayner's Sophi Phacoemulsification System, cleared by the FDA, is now available to US cataract surgeons, enhancing surgical ...

(AP) - U.S. President Donald Trump announced Friday that nine drugmakers have agreed to lower the cost of their prescription drugs in the U.S. Pharmaceutical companies Amgen, Bristol Myers Squibb, ...

President Donald Trump on Friday, Dec. 19, announced nine pharmaceutical companies have agreed to sell medications at lower prices, part of his administration's effort to lower drug prices to levels ...

Brainbees Solutions, the parent of babycare brand FirstCry, is set to acquire hygiene products maker KA Hygiene through a share-swap arrangement. Meanwhile, Aurobindo Pharma and Info Edge will ...

Novo Nordisk NOVO.B1.08%increase; green up pointing triangle filed for U.S. Food and Drug Administration approval of CagriSema, a once-weekly shot that combines two compounds to treat obesity.

The Trump administration on Friday announced new drug-pricing agreements with a number of major European and U.S. drugmakers, following earlier deals with Pfizer, Eli Lilly, and others. Nine companies ...